Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Adamson

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
Pediatric Blood & Cancer|August 11, 2006
A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group StudyPeter C Adamson, Katherine K Matthay, Michelle O'Brien, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|November 15, 2018
The Children's Oncology Group: Organizational Structure, Membership, and Institutional CharacteristicsJanice S Withycombe, Todd A Alonzo, Michele A Wilkins-Sanchez, et al.
Biopharmaceutics & Drug Disposition|August 31, 2004
The plasma pharmacokinetics and cerebral spinal fluid penetration of intravenous topiramate in newborn pigsJeffrey L Galinkin, C Dean Kurth, Heng Shi, et al.
Pediatric Blood & Cancer|September 13, 2011
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962)Samara L Poplack Potter, Stacey Berg, Ashish Mark Ingle, et al.
Pediatric Blood & Cancer|January 31, 2007
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group studyMason Bond, Mark L Bernstein, Alberto Pappo, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 30, 2005
The bioavailability of oral methotrexate in children with inflammatory bowel diseaseMichael C Stephens, Robert N Baldassano, Amy York, et al.
The Lancet. Oncology|February 26, 2013
New drugs for children and adolescents with cancer: the need for novel development pathwaysGilles Vassal, C Michel Zwaan, David Ashley, et al.
Cancer Letters|January 10, 2006
Anticancer effects of fenretinide in human medulloblastomaC Damodar Reddy, Asha Guttapalli, Peter C Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group StudyLisa R Bomgaars, Mark Bernstein, Mark Krailo, et al.
Epilepsia|November 22, 2012
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 monthsTracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Pediatric Blood & Cancer|August 11, 2006
A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group StudyPeter C Adamson, Katherine K Matthay, Michelle O'Brien, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|November 15, 2018
The Children's Oncology Group: Organizational Structure, Membership, and Institutional CharacteristicsJanice S Withycombe, Todd A Alonzo, Michele A Wilkins-Sanchez, et al.
Biopharmaceutics & Drug Disposition|August 31, 2004
The plasma pharmacokinetics and cerebral spinal fluid penetration of intravenous topiramate in newborn pigsJeffrey L Galinkin, C Dean Kurth, Heng Shi, et al.
Pediatric Blood & Cancer|September 13, 2011
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962)Samara L Poplack Potter, Stacey Berg, Ashish Mark Ingle, et al.
Pediatric Blood & Cancer|January 31, 2007
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group studyMason Bond, Mark L Bernstein, Alberto Pappo, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 30, 2005
The bioavailability of oral methotrexate in children with inflammatory bowel diseaseMichael C Stephens, Robert N Baldassano, Amy York, et al.
The Lancet. Oncology|February 26, 2013
New drugs for children and adolescents with cancer: the need for novel development pathwaysGilles Vassal, C Michel Zwaan, David Ashley, et al.
Cancer Letters|January 10, 2006
Anticancer effects of fenretinide in human medulloblastomaC Damodar Reddy, Asha Guttapalli, Peter C Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group StudyLisa R Bomgaars, Mark Bernstein, Mark Krailo, et al.
Epilepsia|November 22, 2012
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 monthsTracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.
Pageof 18